SLU-PP-332

SLU-PP-332 is a potent pan-ERR (Estrogen-Related Receptor) agonist developed for advanced metabolic and mitochondrial research. Originally synthesised at Saint Louis University, SLU-PP-332 selectively activates ERRα, ERRβ, and ERRγ — nuclear receptors that play a central role in regulating oxidative metabolism, energy expenditure, and mitochondrial biogenesis.

Product Specifications

Research Background

ERR receptors are considered master regulators of cellular energy homeostasis. Unlike classical oestrogen receptors, ERRs are constitutively active and respond to synthetic agonists such as SLU-PP-332. Preclinical research has explored this compound in the context of:

• •  Mitochondrial biogenesis — activation of PGC-1α-dependent pathways.
• •  Skeletal muscle oxidative capacity — upregulation of genes governing fatty acid oxidation and electron transport chain function.
• •  Exercise mimicry — modelling the molecular signature of endurance training at the cellular level.
• •  Metabolic dysfunction models — research into obesity, type 2 diabetes, and age-related metabolic decline.

Quality Assurance

Every batch of NueCog SLU-PP-332 undergoes third-party analytical testing. Certificate of Analysis (CoA) available on request. All products are manufactured to research-grade standards under strict quality control protocols.

Read more in our NueCog SLU-PP-332 Research Guide.

Intended Use

This product is sold strictly for laboratory and in-vitro research purposes only. It is not intended for human consumption, veterinary use, or diagnostic application. Not for sale to minors. This product is not a medicine, food supplement, or drug.